JPRN-UMIN000047127尚未招募未知
Phase II study to evaluate the safety and efficacy of endoscopic radiofrequency ablation of the bile duct using the Habib Endo HPB catheter in patients with unresectable cholangiocarcinoma after biliary stent placement. - Phase II study to evaluate the safety and efficacy of endoscopic radiofrequency ablation of the bile duct using the Habib Endo HPB catheter in patients with unresectable cholangiocarcinoma after biliary stent placement.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients in poor general condition who cannot undergo endoscopy (2) Patients taking more than 2 antiplatelet/anticoagulant drugs (3) Patients with a pacemaker implanted (4) Patients with a fever of 37.5 or higher and suspected cholangitis (5) Other patients deemed unsuitable for the procedure by the physician
研究者
相似试验
招募中
2 期
Phase II study of multimodality treatment for ATRTAtypical teratoid rhabdoid tumorD016543JPRN-jRCTs051200071Junichi Hara50
招募中
2 期
Phase II study of new risk classification and high-dose chemotherapy for medulloblastomaJPRN-jRCTs051200021Hara Junichi229
尚未招募
2 期
Phase II study to evaluate the efficacy and safety of mirogabalin for CIPN in patients with gastrointestinal cancer.esophageal cancer, gastric cancer, small bowel cancer, colon cancer, pancreatic cancerJPRN-UMIN000049555ational Cancer Center Hospital30
招募中
2 期
Evaluation of the efficacy of bioadhesive barrier-forming oral liquid gel (Episil) for prevention of oral mucositisJPRN-jRCTs062220023Takano HIdeyuki50
招募中
2 期
Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel maintenance therapy beyond stable disease in patients with advanced relapsed non-squamous NSCLC who received Bevacizumab / pemetrexed / platinum induction therapyJPRN-UMIN000010055Respiratory Center, Showa University Northern Yokohama Hospital20